Ubs Asset Management Americas Inc Akebia Therapeutics, Inc. Transaction History

Ubs Asset Management Americas Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.32 - $0.67 $57,852 - $121,129	-180,790 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.26 - $3.34 $14,954 - $22,100	6,617 Added 3.8%	180,790 $408,000
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.88 $57,732 - $95,319	-24,567 Reduced 12.36%	174,173 $501,000
Q2 2021 Aug 16, 2021	BUY	$2.83 - $4.2 $298,061 - $442,352	105,322 Added 112.74%	198,740 $753,000
Q1 2021 May 14, 2021	BUY	$2.92 - $5.06 $15,586 - $27,010	5,338 Added 6.06%	93,418 $315,000
Q3 2020 Nov 13, 2020	SELL	$2.39 - $13.08 $2,645 - $14,479	-1,107 Reduced 1.24%	88,080 $221,000
Q2 2020 Aug 14, 2020	BUY	$6.67 - $13.58 $67,086 - $136,587	10,058 Added 12.71%	89,187 $1.21 Million
Q1 2020 May 15, 2020	SELL	$4.1 - $10.24 $17,835 - $44,544	-4,350 Reduced 5.21%	79,129 $599,000
Q4 2019 Feb 14, 2020	BUY	$3.16 - $6.73 $10,017 - $21,334	3,170 Added 3.95%	83,479 $527,000
Q3 2019 Nov 14, 2019	BUY	$3.55 - $5.4 $19,446 - $29,581	5,478 Added 7.32%	80,309 $314,000
Q2 2019 Aug 15, 2019	BUY	$4.1 - $8.05 $46,383 - $91,069	11,313 Added 17.81%	74,831 $0
Q1 2019 May 14, 2019	BUY	$5.41 - $8.73 $123,380 - $199,096	22,806 Added 56.02%	63,518 $0
Q4 2018 Feb 13, 2019	BUY	$5.39 - $9.15 $123,495 - $209,644	22,912 Added 128.72%	40,712 $225,000
Q1 2018 May 14, 2018	BUY	$9.53 - $15.68 $169,634 - $279,104	17,800 New	17,800 $0

120

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $338M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.